Anticancer agent 104
Anticancer agent 104 has anticancer activity, and induces cancer cell apoptosis.
For research use only. We do not sell to patients.
- CAS No.: 3047612-51-8
- Formula: C34H47F3N2O2S2
- Molecular Weight:636.87
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 786-0 | IC50 |
91.67 μM
Compound: 4l
|
Anticancer activity against human 786-0 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Anticancer activity against human 786-0 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
| Calu-1 | IC50 |
78.34 μM
Compound: 4l
|
Anticancer activity against human Calu-1 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Anticancer activity against human Calu-1 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
| HEK-293T | IC50 |
195.17 μM
Compound: 4l
|
Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
| HepG2 | IC50 |
31.39 μM
Compound: 4l
|
Anticancer activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Anticancer activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
| Huh-7 | IC50 |
75.18 μM
Compound: 4l
|
Anticancer activity against human Huh-7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Anticancer activity against human Huh-7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
| KGN | IC50 |
176.38 μM
Compound: 4l
|
Cytotoxicity against human KGN cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human KGN cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
| LX-2 | IC50 |
96.33 μM
Compound: 4l
|
Cytotoxicity against human LX2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human LX2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
| MCF-10A | IC50 |
21.06 μM
Compound: 4l
|
Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
| SK-BR-3 | IC50 |
44.18 μM
Compound: 4l
|
Anticancer activity against human SK-BR-3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Anticancer activity against human SK-BR-3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
| SK-OV-3 | IC50 |
112.19 μM
Compound: 4l
|
Anticancer activity against human SK-OV-3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Anticancer activity against human SK-OV-3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
| WI-38 | IC50 |
81.48 μM
Compound: 4l
|
Cytotoxicity against human WI-38 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human WI-38 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 37084600] |
In Vitro
Anticancer agent 104 (Compound 4l) (48 h) is toxic to HepG2 cells (IC50: 31.39 μM)[1].
Anticancer agent 104 (10-200 μg/mL, 48 h) exhibits volume reduction, chromatin margination, and eventually formed apoptotic vesicles[1].
Anticancer agent 104 (10-100 μg/mL, 48 h) induces HepG2 cell apoptosis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Calu-1, SK-BR-3, HUH-7, 786-O, SK-OV-3 cells
-
Concentration:0-200 μM approximately
-
Incubation Time:48 h
-
Result:Shows cytotoxic activities with IC50s of 78.34, 44.18, 75.18, 91.67, 112.19 μM.
-
Cell Line:HepG2 cells
-
Concentration:10, 50 and 100 μg/mL
-
Incubation Time:48 h
-
Result:Showed apoptotic rate of 23.67%, 41.21% and 61.16% respectively.
Chemical Information
-
CAS No. 3047612-51-8
-
Molecular Weight 636.87
-
Formula C34H47F3N2O2S2
-
SMILES
C[C@@]1(C(C)([C@@](CC1)([H])C2)C)[C@@H]2OC(CCC[C@@H]3[C@]4([H])[C@]5([H])[C@](CCCN5CCC4)([H])CN3C(SCC6=CC=C(C=C6)C(F)(F)F)=S)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)